Génome Québec’s Centre d’Expertise et de Services (CES) now offers high-throughput proteomics profiling using the IPP platform. This cutting-edge technology enables the simultaneous quantification of up to 9,500 proteins in a single sample, providing deep insights into biological systems, disease mechanisms, and biomarker discovery.

  • Biomarker discovery and validation
  • Clinical research and translational studies
  • Drug target identification and pharmacodynamics
  • Systems biology and pathway analysis
  • Population-scale proteomics studies

The IPP platform leverages advanced affinity-based proteomics to deliver high sensitivity, reproducibility, and scalability. It is well suited for large cohort studies and projects requiring robust quantitative protein measurements. Interrogate up to 9,500 protein targets per sample with IPP 9.5k, the most complete panel available or choose from one of 5 GQ exclusive expertly curated targeted panels (3000 proteins):

Complete Panel

~ 9,500
proteins

Comprehensive Immunology ~1000 industry-standard analytes + ~2000 additional proteins related to immunity and inflammation
Oncology & Tumour Microenvironment (TME) Tumour biology, growth factors, immune checkpoints and key components of the TME
Neuroscience & Neuroimmunology Synaptic proteins, neuroinflammation, blood-brain barrier (BBB) integrity and microglial activation
Cardiometabolic & Organ Health Lipid metabolism, vascular biology and liver and kidney injury markers
Population Proteomics (UK Biobank-inspired) Designed for large cohorts and proteogenomics
  • Expertise in high-throughput omics technologies
  • End-to-end project support from design to data interpretation
  • Access to state-of-the-art infrastructure
  • Trusted partner for academic, clinical, and industrial clients worldwide
  • Competitive pricing and fast turnaround times

Contact our team to discuss your project or request a quote. We will work with you to design a proteomics study tailored to your research objectives.